Comparison of Oral Nicotinamide Adenine Dinucleotide (NADH) versus Conventional Therapy for Chronic Fatigue Syndrome

COVID-19: NAD+ deficiency may predispose the aged, obese, and type 2 diabetics to mortality through its effect on SIRT1 activity

Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions

Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review

Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease

A Case of Parkinson’s Disease Symptom Reduction with Intravenous NAD+

NAD+ Repletion Rescues Female Fertility during Reproductive Aging